Edgerton S - Search Results

1

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD; ECOG 2100. Schneider BP, et al. Among authors: edgerton s. J Clin Oncol. 2008 Oct 1;26(28):4672-8. doi: 10.1200/JCO.2008.16.1612. J Clin Oncol. 2008. PMID: 18824714 Free PMC article. Clinical Trial.

2

pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.

Thor AD, Koerner FC, Edgerton SM, Wood WC, Stracher MA, Schwartz LH. Thor AD, et al. Among authors: edgerton sm. Breast Cancer Res Treat. 1992;21(2):111-9. doi: 10.1007/BF01836957. Breast Cancer Res Treat. 1992. PMID: 1627814

3

Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit.

Lloveras B, Edgerton S, Thor AD. Lloveras B, et al. Among authors: edgerton s. Am J Clin Pathol. 1991 Jan;95(1):41-7. doi: 10.1093/ajcp/95.1.41. Am J Clin Pathol. 1991. PMID: 1987751

4

Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications.

Thor AD, Edgerton SM. Thor AD, et al. Among authors: edgerton sm. Semin Nucl Med. 1989 Oct;19(4):295-308. doi: 10.1016/s0001-2998(89)80022-4. Semin Nucl Med. 1989. PMID: 2678481 Review.

5

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

Axelsson K, Ljung BM, Moore DH 2nd, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH. Axelsson K, et al. Among authors: edgerton sm. J Natl Cancer Inst. 1995 Jul 5;87(13):997-1008. doi: 10.1093/jnci/87.13.997. J Natl Cancer Inst. 1995. PMID: 7543156

6

p53 mutations in benign breast tissue.

Millikan R, Hulka B, Thor A, Zhang Y, Edgerton S, Zhang X, Pei H, He M, Wold L, Melton LJ, et al. Millikan R, et al. Among authors: edgerton s. J Clin Oncol. 1995 Sep;13(9):2293-300. doi: 10.1200/JCO.1995.13.9.2293. J Clin Oncol. 1995. PMID: 7666086

7

Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay.

Eng Tan P, Benz CC, Dollbaum C, Moore DH 2nd, Edgerton SM, Zava DT, Thor AD. Eng Tan P, et al. Among authors: edgerton sm. Ann Oncol. 1994 Apr;5(4):329-36. doi: 10.1093/oxfordjournals.annonc.a058836. Ann Oncol. 1994. PMID: 8075029 Free article.

8

Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.

Krajewski S, Thor AD, Edgerton SM, Moore DH 2nd, Krajewska M, Reed JC. Krajewski S, et al. Among authors: edgerton sm. Clin Cancer Res. 1997 Feb;3(2):199-208. Clin Cancer Res. 1997. PMID: 9815673 Free article.

9

Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.

Thor AD, Liu S, Moore DH 2nd, Edgerton SM. Thor AD, et al. Among authors: edgerton sm. J Clin Oncol. 1999 Feb;17(2):470-7. doi: 10.1200/JCO.1999.17.2.470. J Clin Oncol. 1999. PMID: 10080587

10

p(21WAF1/CIP1) expression in breast cancers: associations with p53 and outcome.

Thor AD, Liu S, Moore DH 2nd, Shi Q, Edgerton SM. Thor AD, et al. Among authors: edgerton sm. Breast Cancer Res Treat. 2000 May;61(1):33-43. doi: 10.1023/a:1006455526894. Breast Cancer Res Treat. 2000. PMID: 10930088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters